These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4014087)

  • 1. Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa.
    Wilmott RW; Tyson SL; Matthew DJ
    Am J Dis Child; 1985 Jul; 139(7):669-71. PubMed ID: 4014087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection.
    Demko CA; Byard PJ; Davis PB
    J Clin Epidemiol; 1995 Aug; 48(8):1041-9. PubMed ID: 7775991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas infection, allergy, and cystic fibrosis.
    Pitcher-Wilmott RW; Levinsky RJ; Gordon I; Turner MW; Matthew DJ
    Arch Dis Child; 1982 Aug; 57(8):582-6. PubMed ID: 6981383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Viel M; Hubert D; Burgel PR; Génin E; Honoré I; Martinez B; Gaitch N; Chapron J; Kanaan R; Dusser D; Girodon E; Bienvenu T
    Clin Respir J; 2016 Nov; 10(6):777-783. PubMed ID: 25763772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre.
    Proesmans M; Balinska-Miskiewicz W; Dupont L; Bossuyt X; Verhaegen J; Høiby N; de Boeck K
    Eur Respir J; 2006 May; 27(5):937-43. PubMed ID: 16707392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients.
    Derichs N; Mekus F; Bronsveld I; Bijman J; Veeze HJ; von der Hardt H; Tummler B; Ballmann M
    Pediatr Res; 2004 Jan; 55(1):69-75. PubMed ID: 14605249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and laboratory correlations in patients with cystic fibrosis and Pseudomonas aeruginosa infection: The experience of a regional centre.
    Smădeanu R; Moşescu S; Zăpucioiu C; Orăşeanu D
    Pneumologia; 2016; 65(4):201-6. PubMed ID: 29542902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
    Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
    Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.
    Mauch RM; Rossi CL; Nolasco da Silva MT; Bianchi Aiello T; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Med Microbiol Immunol; 2019 Apr; 208(2):205-213. PubMed ID: 30706137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Sansgiry SS; Joish VN; Boklage S; Goyal RK; Chopra P; Sethi S
    J Med Econ; 2012; 15(2):219-24. PubMed ID: 22084956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
    Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
    J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre.
    Nir M; Lanng S; Johansen HK; Koch C
    Thorax; 1996 Oct; 51(10):1023-7. PubMed ID: 8977604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pseudomonas aeruginosa and cystic fibrosis: first colonization to chronic infection].
    Laurans M; Arion A; Fines-Guyon M; Regeasse A; Brouard J; Leclercq R; Duhamel JF
    Arch Pediatr; 2006 Oct; 13 Suppl 1():S22-9. PubMed ID: 17370393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Valerius NH; Koch C; Høiby N
    Lancet; 1991 Sep; 338(8769):725-6. PubMed ID: 1679870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.